CONNECT WITH US
HealthTech

HealthTech

Lawmakers press Oracle CEO on ballooning VA EHR modernization costs

Healthcare Dive logo

Published on

Add as a preferred source on Google
Lawmakers press Oracle CEO on ballooning VA EHR modernization costs

Mike Sicilia, the EHR vendor’s chief executive, defended Oracle’s request for billions of dollars of additional latitute in project spending, arguing its expanded scope necessitates the increase.

It’s the first time Oracle leaders have publicly addressed questions from lawmakers since the VA tacked on billions to the upper limit of the contract’s price in August, raising alarms among lawmakers and prompting them to dish out subpoenas to Oracle’s CEO, Sicilia, and Executive Chairman Larry Ellison.

The VA and Oracle have long faced intense scrutiny over the EHR modernization program, which was designed to promote interoperability and standardize records at VA medical centers. However, it has been plagued by delays, mounting costs and technical challenges.

The original contract was inked with Cerner in 2018. Oracle inherited the project when it acquired Cerner in 2022. By 2023, just five VA medical centers out of 170 had deployed the new EHR. Negative feedback, outages and other problems forced the VA to pause the project that year to renegotiate its contract with Oracle and address performance issues.

The VA and Oracle restarted deployments in April, rolling out the EHR at 13 VA medical centers. Another 26 medical centers are on the schedule for next year, and the VA plans to complete 170 site deployments by 2031.

Lawmakers acknowledged that this year’s deployments have gone smoother than those that came before. But they still have concerns about the price tag and are pressing Sicilia for answers.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.